Hydrocortison med Terramycin

Quick links

Choose a section

Quick links to important sections

Advertisements

Hydrocortison med Terramycin

Advertisements
Advertisements

Overview of Hydrocortison med Terramycin

Property Description
Active Ingredients Hydrocortisone, Oxytetracycline Hydrochloride
Form Ointment, Suspension (Ophthalmic/Otic)
Pharmacological Class Combination Antibiotic and Corticosteroid
General Purpose Managing localized inflammation and bacterial presence
Origin Synthetic/Semi-synthetic

What Type of Combination Product is Hydrocortison med Terramycin?

Hydrocortison med Terramycin is defined as a prescription-only combination product intended for topical administration, pairing a corticosteroid with a broad-spectrum antibiotic. This combination is strategically utilized in localized conditions, a therapeutic approach clinically recognized for addressing issues of dual etiology. The formulation utilizes two distinct pharmacological classes: the glucocorticoid Hydrocortisone and the tetracycline antibiotic Oxytetracycline. It is supplied primarily as a sterile Ointment or Suspension suitable for application to the skin or specific superficial areas, including the eye (Ophthalmic) or ear (Otic).


What is Hydrocortison med Terramycin Made Of?

The core structure of the medication includes the two active ingredients: Hydrocortisone and Oxytetracycline Hydrochloride. Hydrocortisone acts as a mild-potency steroid, providing the necessary anti-inflammatory action by reducing the redness and swelling associated with irritation. Oxytetracycline Hydrochloride is the antibacterial component, functioning as a bacteriostatic agent that works by halting the growth of susceptible bacteria. This dual composition is distinct from single-agent preparations, providing a focused solution for conditions where both inflammation and bacterial involvement are present. These active substances are blended into a neutral vehicle, such as a Sterile Petroleum Base, ensuring the product is stable and appropriate for direct external contact.


What is the General Purpose of this Dual-Action Formulation?

The fundamental purpose of this dual-action formulation is to provide integrated relief by simultaneously addressing the painful symptoms of inflammation and the cause of bacterial proliferation. The combined effect is designed to rapidly reduce localized inflammation—alleviating symptoms like redness, swelling, and itching—while the antibiotic component controls or prevents an accompanying bacterial infection. This offers a comprehensive approach to managing localized conditions where both inflammation and bacterial involvement coexist.

Regulatory References

  1. National Institutes of Health, DailyMed (Terra-Cortril)
Advertisements

What side effects are possible with Hydrocortison med Terramycin?

The safety profile for the Hydrocortisone and Oxytetracycline combination product outlines adverse reactions primarily localized to the application site, with specific considerations for the potential effects of the corticosteroid component.

Adverse Reaction Scope

The most commonly documented reactions affect the Ocular and Dermatological systems. Common expected reactions include localized irritation, burning, itching, and dryness. More specific dermatological effects listed are folliculitis, skin atrophy, and striae.

Serious adverse reactions are related to the corticosteroid component. In ophthalmic use, these include elevated intraocular pressure which may progress to glaucoma and optic nerve damage, as well as posterior subcapsular cataract formation. Systemic absorption of the topical corticosteroid may lead to reversible hypothalamic-pituitary-adrenal (HPA) axis suppression and manifestations of Cushing's syndrome, particularly with enhanced absorption conditions.

Frequency and Time-Related Safety

Adverse reactions are classified according to frequency, though specific terms may vary by regulatory document. Hypersensitivity reactions, such as contact dermatitis, are generally listed as rare. Prolonged use of the product is explicitly associated with an increased risk of both ocular damage and the development of secondary infection, including fungal infections of the cornea.

Population-Specific Safety

Official labeling defines specific constraints for certain patient groups. Pediatric patients are noted to have greater susceptibility to systemic toxicity from the corticosteroid, potentially leading to signs like linear growth retardation. The product is generally contra-indicated during pregnancy and lactation due to the theoretical risk of permanent dentition damage from the oxytetracycline component. Conditions that increase absorption, such as using occlusive dressings or application to large surface areas, increase the potential for systemic adverse effects.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for this combination topical product primarily addresses risks arising from accidental ingestion or chronic, excessive topical use leading to systemic absorption of the active ingredients.

Scenario Documented Manifestations
Chronic Overdose (Prolonged Use) Symptoms of Hypothalamic-Pituitary-Adrenal (HPA) axis suppression and features resembling Cushing's syndrome from the absorbed hydrocortisone. Increased risk of secondary infection due to overgrowth of non-susceptible organisms.
Acute Overdose (Ingestion) Gastrointestinal distress (e.g., nausea, vomiting, diarrhea). Rarely, symptoms of severe hypersensitivity or anaphylaxis related to the active components.

Required Emergency Actions

If overdose is suspected, discontinue the medication immediately. For suspected acute ingestion, regulatory guidance requires users to call a Poison Control Center immediately. Seek immediate medical attention for severe allergic reactions or signs of acute systemic toxicity. Urgent care is also required for symptoms indicative of systemic steroid excess or adrenal insufficiency.

Management is generally symptomatic and supportive, as no specific antidote is known for the oxytetracycline component. Pediatric patients face a heightened risk of systemic toxicity from topical corticosteroids because of their greater skin surface area-to-body weight ratio. For ophthalmic use lasting 10 days or longer, regulatory guidance requires routine monitoring of intraocular pressure.

Advertisements

Therapeutic Uses of Hydrocortison med Terramycin

What Hydrocortisone with Terramycin Treats: Main Uses and Benefits

The combination of Hydrocortisone and Terramycin (Oxytetracycline) is a combination treatment generally used to provide supportive symptomatic relief for conditions characterized by periods of heightened symptoms in contexts involving inflammatory or irritative processes. This medicine is applied to address symptoms related to inflammatory or irritative states.

This treatment is commonly used across domains where short-term symptom management is appropriate, assisting with conditions that present with systemic or localized discomfort and inflammatory or irritative processes.

Easing Symptomatic Burden

This medicine is applied across domains where additional symptomatic support is needed, particularly for symptoms related to inflammatory or irritative states that may become intense or disruptive. It contributes to improved comfort during periods of heightened symptoms, offering supportive relief when symptoms that interfere with daily functioning become noticeable. The treatment helps ease the overall symptom burden and supports general well-being during symptomatic phases.

“It supports patients during difficult episodes by easing distress and is applied in clinical settings that involve acute or unstable symptom patterns.”

Quick Fact: Support for Acute Discomfort

Managing Disruptive Symptom Patterns

Relevant in contexts marked by increased discomfort or tension, this formulation is applied in addressing symptom clusters that appear suddenly or fluctuate. It helps patients cope more steadily with symptom fluctuations and assists with maintaining functional stability when symptoms create noticeable physiological strain.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Hydrocortisone med Terramycin?

Eligibility for Hydrocortisone med Terramycin (Oxytetracycline/Hydrocortisone) is strictly defined by regulatory documents, focusing on patient age, physiological state, and existing infections. This medicine must not be used by individuals with a known hypersensitivity to any of its components.

Contraindicated Populations

The medicine is formally contra-indicated during pregnancy and lactation (nursing mothers) due to the theoretical risk posed by the tetracycline component. It is also not recommended for infants and small children.

Infectious Restrictions

Use is prohibited when specific viral diseases are present at the application site, including herpes simplex, vaccinia, or varicella, and in the presence of fungal diseases or primary bacterial infections such as pyoderma or impetigo. The steroid component may mask or enhance these conditions.

Conditional Use

Use requires caution in patients with glaucoma (for ophthalmic preparations). Otic preparations are not recommended for patients with a perforated eardrum. For approved indications, treatment should not be continued for more than seven days in the absence of clinical improvement.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation for this combination product, which contains Oxytetracycline Hydrochloride and Hydrocortisone, describes a restricted interaction profile centered on the topical route of administration.

Established Drug-Drug Interaction Status

Official regulatory sources assert that for the typical, localized use of the topical formulation (Ointment or Suspension), no specific drug–drug interactions are formally established with other medicinal products. Furthermore, no interactions with food, alcohol, or herbal products are documented in the regulatory labeling.

Interaction Type Regulatory Status (Topical Formulation)
Formal Contraindicated Combinations None established.
Metabolic (CYP) Interactions None established.
Timing-Separation Rules None established.

Conditional Exposure Risk (Pharmacokinetic)

The labeling identifies a conditional risk related to the method of administration, which may alter drug exposure. This risk is classified as a pharmacokinetic pattern affecting the corticosteroid component.

Specifically, the potential for increased systemic absorption of Hydrocortisone is documented when the product is applied to extensive surface areas, utilized under an occlusive technique, or used for prolonged periods. These administration constraints are the primary interaction-related considerations noted in official regulatory information, defining the product's overall interaction structure.

Advertisements

Mechanism of Action

The pharmacological activity of this topical combination is driven by two distinct and complementary mechanistic domains that target separate biological entities: host inflammatory pathways and bacterial ribosomal components.

Modulating Tissue Inflammation via Glucocorticoid Receptor Agonism

The Hydrocortisone component acts as an agonist of the cytosolic Glucocorticoid Receptor (GR), initiating a genetic cascade known as transrepression. This molecular action suppresses the synthesis of pro-inflammatory mediators like cytokines and blocks the enzyme Phospholipase A2 ( PLA2), thereby inhibiting the production of key mediators such as prostaglandins. This mechanism contributes to a physiological consequence of decreased vascular permeability and vasoconstriction, by limiting the mobilization of inflammatory cells and the leakage of fluid into the tissue.

Arresting Bacterial Growth via 30S Ribosomal Inhibition

The Oxytetracycline component acts directly on susceptible bacteria by functioning as a reversible inhibitor of protein synthesis. It binds specifically to the 30S ribosomal subunit at the A-site, which effectively halts the elongation of the bacterial peptide chain and prevents cell replication. This targeted action results in a bacteriostatic effect, which inhibits the proliferation and replication of susceptible microbial populations at the site of application.

Coordinated Mechanistic Synergy

The combination provides a complementary dual mechanism where GR-agonism modulates inflammatory pathways, and 30S ribosomal inhibition modulates microbial proliferation. This integration targets two distinct biological processes simultaneously.

Advertisements

Dosage and Administration Information

Official Administration Guidelines for Combination Product Use

This medication, which combines Oxytetracycline (an antibiotic) and Hydrocortisone (a corticosteroid), is strictly designated for topical use in specific external areas of the body. Standard guidelines define precise routes, quantities, and schedules for its correct administration.

Administration Scope

Feature Standard Administration Instructions
Route of administration Topical (skin), Ophthalmic (eye), and Otic (ear), depending on the specific dosage form (Ointment or Suspension).
Dosing schedule Ophthalmic Suspension: Instil 1 to 2 drops. Topical Ointment: Apply a small amount to the affected area.
Frequency pattern Multiple times daily, typically administered two to four times a day depending on the formulation and site of application.
Preparation requirements The Suspension must be shaken well immediately before each use. The affected area for the ointment should be cleaned thoroughly before application.
Course duration / Restrictions The treatment is designated for short-term use. The topical ointment should not be continued for more than seven days if clinical improvement is absent.
Age-group rules The Topical Ointment is not recommended for use in children.

Resulting Procedural Structure

The official usage protocol requires the correct formulation to be matched to the intended route, strictly adhering to the specified quantity and application frequency. For the suspension, proper mixing is necessary before application, and the patient must take care to avoid contamination of the tip of the tube or dropper. The instructions restrict the duration of use to a short course and stipulate that topical ointment formulations are not intended for ophthalmic use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hydrocortison med Terramycin


Evidence for Use in Conditions Associated with Acute External Otitis

Research has examined the use of this combination product in patients experiencing acute external otitis, which are conditions involving periods of heightened symptoms in the ear canal. The available evidence includes short-term, single-blind randomized studies where the product was evaluated in trials that included other active compounds.

These studies examined outcomes such as measures of symptom change (often described as a cure rate) and measures of microbial eradication in the ear. While this evidence contributes to the broader evidence landscape, comparative evidence is lacking on how this product was evaluated against a non-active or placebo control. Long-term effects are not fully established, meaning the frequency of symptoms returning after the treatment period is not well characterized by the current evidence.


Evidence for Use in Post-Extraction Surgical Recovery

The product was studied for application in the context of post-surgical recovery, specifically following the removal of impacted mandibular third molars (wisdom teeth). Research on this use includes randomized controlled trials as well as observational studies. These studies evaluated several patient-reported outcomes describing perceived discomfort.

Research examined measures related to outcomes linked to inflammatory or irritative states, such as assessments of pain levels and swelling in the days immediately following surgery. Findings were mixed regarding measures of long-term healing, and certainty remains low in that area. The results apply only to the populations studied—medically healthy adults undergoing this specific type of surgery.


What is Still Uncertain in the Research

A consistent limitation across the evidence base is that follow-up durations were limited in many key studies. Data for certain groups remain insufficient. For instance, evidence describing the use of this combination product in pediatric patients or in older adults is often limited. Furthermore, the evidence quality varies across studies, leading to different results, particularly in the dental context where findings were mixed regarding long-term healing.

Key Studies & References

  1. Retrospective analysis for predictors of postsurgical complications from third molar extraction with use of oxytetracycline–hydrocortisone‐coated gauze inserted in extraction socket
  2. 21 CFR § 524.1662b Oxytetracycline hydrochloride, polymyxin B sulfate ophthalmic ointment (Regulatory basis for combination components)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Hydrocortison med Terramycin (FAQ)

Q: How quickly does Hydrocortison med Terramycin usually start to work?

Information about topical corticosteroids suggests that anti-inflammatory effects, such as relief from itching and swelling, may begin to be seen shortly after the first use. The intended anti-bacterial effect of the oxytetracycline component is associated with continued use of the product, consistent with the overall prescribed regimen.


Q: What happens if I forget to use a dose?

Official guidance describes that if an application is missed, it can be used as soon as the user remembers. However, if it is almost time for the next application, the forgotten dose is typically skipped. It is noted that a double amount should not be used to compensate for a forgotten dose.


Q: Is Hydrocortison med Terramycin available over-the-counter in some places?

Official labeling in major regulatory regions defines this combination product as a prescription-only medicine. While some lower-strength, single-ingredient hydrocortisone creams may be available without a prescription, this dual-component formulation generally requires a prescription from a healthcare provider.


Q: Why is it necessary to complete the full course of treatment even if symptoms improve quickly?

Completing the full course of treatment is consistent with the goal of ensuring the antibacterial component fully addresses the bacterial presence. This practice helps to minimize the potential for drug-resistant bacteria to develop, which is a standard consideration for antibiotic treatments.


Q: Is there a risk of developing resistance to the antibiotic part of the drug?

Official product warnings state that the use of the oxytetracycline component, like other antibiotics, may lead to the overgrowth of non-susceptible organisms (bacteria or fungi not affected by the medicine). This possibility is a factor considered in the monitoring of treatment by a healthcare professional.


Q: Are there any food or drink interactions while using Hydrocortison med Terramycin?

Regulatory documentation confirms that for the topical formulation of this product, no specific interactions with food, alcohol, or herbal products are established or noted in the official labeling.


Q: What are the typical signs that the medication is working?

The mechanism of action for this combination product suggests that signs of effectiveness include a reduction in localized inflammation—meaning less redness, swelling, and itching. Simultaneously, the antibiotic component is intended to control or prevent the bacterial involvement in the treated area.


Q: Can this product be used on the face or sensitive skin areas?

Official product information notes that using topical steroids on delicate skin sites, such as the face or the diaper area in children, may increase the chance of the medicine being absorbed by the body. For sensitive skin, general guidance suggests that prolonged use is typically avoided to mitigate the risk of adverse effects.


Q: Does using this product increase my sensitivity to sunlight?

The antibiotic component, oxytetracycline, belongs to a class of medicines (tetracyclines) that may be associated with photosensitivity. This means there is a potential for an exaggerated sunburn-like reaction when the treated area is exposed to direct sunlight or ultraviolet light.


Q: Does the efficacy of Hydrocortison med Terramycin decrease over time?

While regulatory sources do not directly address decreased efficacy, they describe that stopping the medicine after long-term use can sometimes lead to the reappearance of symptoms. The official documentation describes that this 'rebound' effect is a noted factor regarding the use of topical steroids.


Q: Are there different strengths of Hydrocortison med Terramycin available?

Regulatory documents describe the specific concentrations of the active ingredients, Hydrocortisone and Oxytetracycline Hydrochloride, within the official Ointment or Suspension formulations. Official labeling documents do not typically list multiple different concentration combinations for this specific combination product.


Q: Is it common for doctors to recommend a tapering process when stopping this drug?

Official product information for topical steroid products states that if they are used for long periods of time, the drug is typically withdrawn gradually instead of being stopped suddenly. This gradual reduction helps reduce the risk of potential withdrawal symptoms.


Q: Does Hydrocortison med Terramycin affect the immune system on the skin?

The hydrocortisone component is a steroid that acts to calm down the body’s local immune response to injury or irritation, which reduces inflammation. Regulatory warnings also state this action can potentially suppress the local immune response, which is a factor in the noted risk of secondary infections.


Q: Do the official documents describe the types of bacteria Terramycin is effective against?

Official documentation describes the susceptible microbial profile for the oxytetracycline (Terramycin) component. This includes various strains of bacteria, such as certain types of staphylococci, streptococci, pneumococci, and Hemophilus influenzae. The specific details are available in the official product labeling.

Advertisements

How should Hydrocortison med Terramycin be stored and disposed of?

How to Store and Dispose of Hydrocortisone with Terramycin

The storage and disposal instructions for products containing Hydrocortisone and Oxytetracycline must strictly adhere to official regulatory labeling to ensure product quality and safety.

Storage Requirements

Requirement Official Instruction
Temperature Store at Controlled Room Temperature (20 C to 25 C).
Protection Protect from freezing and keep tightly closed to maintain container integrity.
Safety The medicine must be kept out of the reach and sight of children.

Disposal Guidance

Unused or expired medication should be disposed of primarily through a community drug take-back program or pharmacy collection point. If such programs are unavailable, disposal in household trash may be permitted, provided the medication is mixed with an undesirable substance (e.g., coffee grounds) and sealed in a container to prevent misuse. The product must not be poured down a sink or flushed down a toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hydrocortison med Terramycin found in:

A-Z Index: